Exactly. That is why the extreme liberal liars and shills for Big Pharma are discrediting it. Way cheaper and more effective. Ivermectin is dirt cheap compared to the vaccines they are selling to the US government and other countries.
Phil Valentine, who took ivermectin instead of a vaccine, is now on a ventilator
- Thread starter exGOPer
- Start date
Exactly. That is why the extreme liberal liars and shills for Big Pharma are discrediting it. Way cheaper and more effective. Ivermectin is dirt cheap compared to the vaccines they are selling to the US government and other countries.
Ivermectin: a multifaceted drug of Nobel prize-honored distinction with indicated efficacy against a new global scourge, COVID-19
https://www.sciencedirect.com/science/article/pii/S2052297521000883
This "study" is laughable. Even the country of Peru (promoted in this study) currently states that Ivermectin is useless for treating COVID and should not be used. Yet many people are still taking Ivermectin in Peru which has not stopped their 2021 COVID surge -- only vaccination will slow COVID down.
Some background...
https://www.isglobal.org/en/healthi...of-several-latin-american-countries/2877257/0
For treating worms. It's not even an anti-viral drug.
Let's see what the manufacturer of Ivermectin, Merck, has to say...
Merck Statement on Ivermectin use During the COVID-19 Pandemic
https://www.merck.com/news/merck-statement-on-ivermectin-use-during-the-covid-19-pandemic/
KENILWORTH, N.J., Feb. 4, 2021 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today affirmed its position regarding use of ivermectin during the COVID-19 pandemic. Company scientists continue to carefully examine the findings of all available and emerging studies of ivermectin for the treatment of COVID-19 for evidence of efficacy and safety. It is important to note that, to-date, our analysis has identified:
- No scientific basis for a potential therapeutic effect against COVID-19 from pre-clinical studies;
- No meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease, and;
- A concerning lack of safety data in the majority of studies.
Yeabut... if the drug companies can sell it for only $1/dose, it won't be used.
Some things are becoming apparent I would say. Always follow da munny.
As outlined by drug watch the average price of Ivermectin is 4 times higher than $1 per dose.
As noted in drug patent watch, Ivermectin’s original U.S. patent may have expired in 1996 but there are 12 additional U.S follow-up patents for Ivermectin plus 102 foreign patents. Most companies (in fact all) producing genetics for Ivermectin simply find it best to navigate this patent maze by manufacturing under license agreement with Merck. This allows support from Merck while alleviating all possible patent entanglements. Of course Merck makes money off of these agreements. There are 10 suppliers of Ivermectin listed worldwide.
According to drug patent watch -- the pricing information for Ivermectin is about $4 per unit.
Oh, my bad. I thought you were referring to India in the other post.